These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 7007189

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of desferrioxamine on iron elimination in children after multiple transfusions].
    Leggio ML.
    Minerva Pediatr; 1966 Feb 04; 18(3):101-3. PubMed ID: 5930397
    [No Abstract] [Full Text] [Related]

  • 3. [Chelating therapy in beta-thalassemia].
    Musumeci S, Romeo MA, Di Gregorio F, Schiliró G, Russo G.
    Pediatr Med Chir; 1982 Feb 04; 4(1-2):55-9. PubMed ID: 7111040
    [Abstract] [Full Text] [Related]

  • 4. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ, Grady RW.
    Semin Hematol; 1995 Oct 04; 32(4):304-12. PubMed ID: 8560288
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
    Cooper B, Bunn HF, Propper RD, Nathan DG, Rosenthal DS, Moloney WC.
    Trans Assoc Am Physicians; 1977 Oct 04; 90():335-41. PubMed ID: 611665
    [No Abstract] [Full Text] [Related]

  • 6. Desferrioxamine-induced iron outputs in Cooley's anemia. Results and perspectives.
    Cantore N, Tortarolo M, Volpe E, Gonnella F, Valente A, Buonanno G.
    Haematologica; 1981 Apr 04; 66(2):196-207. PubMed ID: 6791996
    [No Abstract] [Full Text] [Related]

  • 7. Iron metabolism and iron chelation in the thalassaemia disorders.
    Pippard MJ.
    Haematologica; 1990 Apr 04; 75 Suppl 5():66-71. PubMed ID: 2086383
    [No Abstract] [Full Text] [Related]

  • 8. [Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease].
    Cartei G, Cazzavillan M, Chisesi T, Battista R, Barbui T, Dini E.
    Minerva Med; 1978 Mar 17; 69(13):811-21. PubMed ID: 643223
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical management of beta-thalassemia.
    Graziano J, Piomelli S.
    Tex Rep Biol Med; 1978 Mar 17; 40():355-64. PubMed ID: 7034276
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
    Delea TE, Hagiwara M, Thomas SK, Baladi JF, Phatak PD, Coates TD.
    Am J Hematol; 2008 Apr 17; 83(4):263-70. PubMed ID: 17924547
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Changes in urinary iron in thalassemia major in relation to the administration of desferrioxamine].
    Esposito L, Ferrara M, Galdo Capotorti M.
    Pediatria (Napoli); 1978 Mar 31; 86(1):69-76. PubMed ID: 683795
    [No Abstract] [Full Text] [Related]

  • 15. [Longitudinal growth of patients with homozygote beta-thalassemia during continuous subcutaneous infusion of deferoxamine].
    Krüger N, Stubbe P, Tillmann W, Schröter W.
    Dtsch Med Wochenschr; 1986 Jan 31; 111(5):176-81. PubMed ID: 3943469
    [Abstract] [Full Text] [Related]

  • 16. Desferrioxamine induced urinary iron excretion in thalassemia.
    Dubey AP, Kumar S, Choudhury P, Talukdar B, Puri RK.
    Indian Pediatr; 1993 Jun 31; 30(6):775-8. PubMed ID: 8132258
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The treatment of hemosiderosis in thalassaemia major with desferrioxamine-B.
    Kirimlidis S, Philippidis P, Drossos C, Economidis J.
    Helv Paediatr Acta; 1966 Sep 31; 21(4):343-50. PubMed ID: 5997620
    [No Abstract] [Full Text] [Related]

  • 19. Effect of subcutaneous deferoxamine and oral vitamin C on iron excretion in congenital hypoplastic anemia and refractory anemia associated with the 5q-syndrome.
    Ambruso DR, Mahony BS, Githens JH, Rhoades ED.
    Am J Pediatr Hematol Oncol; 1982 Sep 31; 4(2):115-23. PubMed ID: 7114394
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of iron balance in homozygous beta-thalassemia subjects treated with desferrioxamine administered subcutaneously].
    Ferrara M, Galdo Capotorti M, Ponte G, Esposito L.
    Pediatria (Napoli); 1983 Sep 31; 91(4):371-7. PubMed ID: 6545400
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.